On being less tolerant: Enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation Journal Article


Authors: Lesokhin, A. M.; Callahan, M. K.; Postow, M. A.; Wolchok, J. D.
Article Title: On being less tolerant: Enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation
Abstract: The recent approvals of two drugs that block the function of the immune checkpoint programmed cell death 1 (PD-1) have firmly planted tumor immunotherapy in the mainstream of clinical oncology. We provide a historical and immunologic context for these recent advances and discuss translational studies that provide insight into the efficacy of cancer immunotherapy at the individual patient level. © 2015, AAAS. All rights reserved.
Keywords: signal transduction; unclassified drug; review; hepatitis; cisplatin; diarrhea; drug efficacy; drug safety; nonhuman; drug targeting; paclitaxel; colorectal cancer; carboplatin; dacarbazine; ipilimumab; ticilimumab; unindexed drug; cancer immunotherapy; melanoma; neuropathy; kidney carcinoma; monoclonal antibody; arthralgia; pneumonia; prostate cancer; pruritus; rash; t lymphocyte receptor; immunological tolerance; hematologic malignancy; drug mechanism; pancreatitis; drug response; colitis; cell cycle checkpoint; hypothyroidism; peptide vaccine; immunosurveillance; cell interaction; drug tolerance; cytopenia; t lymphocyte activation; tgn 1412; uveitis; non small cell lung cancer; myopathy; adrenal insufficiency; randomized controlled trial (topic); phase 2 clinical trial (topic); phase 3 clinical trial (topic); phase 1 clinical trial (topic); hypophysitis; vitiligo; conjunctivitis; thyroiditis; cp 870893; nephritis; nivolumab; amp 224; mpdl 3280a; pidilizumab; pf 05082566; trx 518; urelumab; human; priority journal; dacetuzumab; pembrolizumab; durvalumab; bms 956559; bms 986016; imp 321; med i6469; mga 271; mk 4166; moxr 0916; msb 0010718 c; varlilumab
Journal Title: Science Translational Medicine
Volume: 7
Issue: 280
ISSN: 1946-6234
Publisher: American Association for the Advancement of Science  
Date Published: 2015-03-25
Start Page: 280sr1
Language: English
DOI: 10.1126/scitranslmed.3010274
PROVIDER: scopus
PUBMED: 25810313
DOI/URL:
Notes: Export Date: 4 May 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok
  2. Michael Andrew Postow
    361 Postow
  3. Margaret Kathleen Callahan
    197 Callahan
  4. Alexander Meyer Lesokhin
    363 Lesokhin